Generation Bio Co. (NASDAQ: GBIO) related to its sale to XOMA Royalty Corporation. Under the terms of the proposed transaction, Generation Bio shareholders are expected to receive $4.2913 in cash per share and one non-transferable contingent value right per share entitling Generation Bio shareholders to receive potential payments under certain conditions.